4BIO Capital Portfolio Company Redpin Therapeutics to be Acquired by Kriya Therapeutics
16 nov. 2022 08h00 HE
|
4Bio Capital
Press Release 4BIO Capital Portfolio Company Redpin Therapeutics to be Acquired by Kriya Therapeutics 16 November 2022 London & New York – 4BIO Capital (“4BIO” or “the Group”), an international...